TRIM21 regulates SREBF1 protein stability through ubiquitination to weaken kidney cancer onset [21], and in liver cancer, TRIM21 enhances progression via inhibiting p62-Keap1-Nrf2 pathway [22]. Here, TRIM21 is linked to liver cancer.